EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,587,462 | -26.9% | 164,075 | -9.9% | 0.00% | – |
| Q2 2023 | $3,538,955 | -49.3% | 182,045 | -25.9% | 0.00% | -100.0% |
| Q1 2023 | $6,973,629 | -4.7% | 245,810 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $7,315,626 | +19.4% | 250,278 | +7.9% | 0.00% | 0.0% |
| Q3 2022 | $6,128,000 | -35.0% | 231,991 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $9,432,000 | +29.4% | 212,309 | +44.1% | 0.00% | 0.0% |
| Q1 2022 | $7,290,000 | +8.1% | 147,295 | +11.3% | 0.00% | 0.0% |
| Q4 2021 | $6,741,000 | -18.7% | 132,386 | -11.0% | 0.00% | 0.0% |
| Q3 2021 | $8,294,000 | +15.4% | 148,697 | -11.5% | 0.00% | 0.0% |
| Q2 2021 | $7,188,000 | +10.6% | 167,926 | +7.8% | 0.00% | 0.0% |
| Q1 2021 | $6,500,000 | -24.1% | 155,733 | -15.3% | 0.00% | 0.0% |
| Q4 2020 | $8,565,000 | +20.9% | 183,925 | +10.2% | 0.00% | 0.0% |
| Q3 2020 | $7,087,000 | +189.1% | 166,829 | +226.6% | 0.00% | 0.0% |
| Q2 2020 | $2,451,000 | +8.0% | 51,082 | +3.6% | 0.00% | 0.0% |
| Q1 2020 | $2,269,000 | -46.6% | 49,309 | -30.3% | 0.00% | 0.0% |
| Q4 2019 | $4,253,000 | -21.6% | 70,782 | -26.2% | 0.00% | 0.0% |
| Q3 2019 | $5,423,000 | -31.5% | 95,847 | -32.6% | 0.00% | -50.0% |
| Q2 2019 | $7,921,000 | +114.0% | 142,256 | +94.0% | 0.00% | +100.0% |
| Q1 2019 | $3,702,000 | +2.6% | 73,319 | -18.1% | 0.00% | 0.0% |
| Q4 2018 | $3,608,000 | -50.8% | 89,544 | -15.3% | 0.00% | -50.0% |
| Q3 2018 | $7,329,000 | -42.0% | 105,710 | -36.7% | 0.00% | -33.3% |
| Q2 2018 | $12,631,000 | +67.4% | 166,956 | +16.6% | 0.00% | +50.0% |
| Q1 2018 | $7,546,000 | -15.3% | 143,215 | -14.2% | 0.00% | 0.0% |
| Q4 2017 | $8,912,000 | -21.7% | 166,857 | -12.6% | 0.00% | -33.3% |
| Q3 2017 | $11,386,000 | -50.3% | 190,911 | -34.3% | 0.00% | -57.1% |
| Q2 2017 | $22,912,000 | +7.6% | 290,429 | +13.1% | 0.01% | +133.3% |
| Q1 2017 | $21,300,000 | -22.0% | 256,828 | -25.4% | 0.00% | -25.0% |
| Q4 2016 | $27,324,000 | +33.5% | 344,366 | +17.8% | 0.00% | -42.9% |
| Q3 2016 | $20,471,000 | -26.2% | 292,439 | -59.1% | 0.01% | -30.0% |
| Q2 2016 | $27,740,000 | +2786.6% | 715,153 | +2913.7% | 0.01% | – |
| Q1 2016 | $961,000 | -77.2% | 23,730 | -50.1% | 0.00% | -100.0% |
| Q4 2015 | $4,213,000 | +250.2% | 47,523 | +192.4% | 0.00% | – |
| Q3 2015 | $1,203,000 | -38.5% | 16,250 | -32.8% | 0.00% | -100.0% |
| Q2 2015 | $1,955,000 | -76.3% | 24,178 | -87.7% | 0.00% | -66.7% |
| Q1 2015 | $8,233,000 | +9473.3% | 196,543 | +3422.3% | 0.00% | – |
| Q4 2014 | $86,000 | +32.3% | 5,580 | +7.7% | 0.00% | – |
| Q3 2014 | $65,000 | +441.7% | 5,183 | +543.9% | 0.00% | – |
| Q2 2014 | $12,000 | -95.9% | 805 | -96.5% | 0.00% | – |
| Q1 2014 | $291,000 | – | 22,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |